Accurant Biotech
  • Home
  • About
    • About Us
    • Leadership Team
  • Services
    • PK/PD
    • ADA
    • NAb
    • Biomarkers
    • Receptor Occupancy
    • CMC
    • Tissue Platform
    • Past & Current Experiences
  • Platform
    • Cell Platform
    • Protein Platform
    • Gene Platform
    • Tissue Platform
  • Contact
  • Blog
  • China Site
  • Career
Select Page

Overcome the Difficulties of Bioanalysis in the Application of Gene Therapy Drugs with AAV as a Vector

by Jasper Yu | Aug 16, 2022 | Uncategorized

Overcome the difficulties of bioanalysis in the application of gene therapy drugs with AAV as a vector Preface The concept of gene therapy was proposed in the early 1970s. The original concept was to introduce a normal copy of a gene to replace a mutated counterpart....

The Method of Improving Drug Tolerance in The ADA Testing Process

by Andy | Sep 13, 2021 | Uncategorized

Almost all biopharmaceutical products will cause a certain anti-drug antibody (ADA) response after entering the body, which refers to immune response. ADA may affect or change the pharmacodynamic effect between the therapeutic protein and its target. Its...
The Application of Minimum Required Dilution (MRD) in ADA Methods

The Application of Minimum Required Dilution (MRD) in ADA Methods

by Andy | Jul 23, 2021 | Uncategorized

Minimum Required Dilution (MRD) is used in almost all PK and ADA (including Biomarker and Nab) methods. Usually, all samples in an analysis plate, including standard curve points, quality control samples, and unknown samples, will be diluted multiple folds in the...
Development of Stable Cell Lines For Cell-Based Functional Assay

Development of Stable Cell Lines For Cell-Based Functional Assay

by Andy | Jul 23, 2021 | Uncategorized

Based on protein interaction, Bioassays mainly include two types: ligand-binding assay (LBA)-based method and MOA (Mode of Action)-based method with cell experiment. LBA-based methods are used for drug affinity test, blood drug concentration test, biomarker...

Recent Posts

  • Overcome the Difficulties of Bioanalysis in the Application of Gene Therapy Drugs with AAV as a Vector
  • The Method of Improving Drug Tolerance in The ADA Testing Process
  • The Application of Minimum Required Dilution (MRD) in ADA Methods
  • Development of Stable Cell Lines For Cell-Based Functional Assay

Recent Comments

    Accurant Biotech Logo
    • Follow
    • Follow

    U.S. Site

    259 Prospect Plains Rd.
    Building H, Suite 168
    Cranbury, NJ 08512

    Tel: +1-732-783-7398
    Fax: +1-732-823-1017

    bd@accurantbiotech.com

    Shanghai Site

    Room 505, Floor 5
    No. 8, Jiafeng Rd.
    Free Trade Zone
    Shanghai, China

    Tel: +86-021-50833588

    customer‑services
    @accurantbio.com

    Ningbo Site

    Floor 4, Building A5
    No. 587, Juxian Rd.
    High-Tech Zone
    Ningbo, China

    Tel: +86-0574-87878487

    customer‑services
    @accurantbio.com

    • About Us
    • Our Services
    • Leadership Team
    • Contact Us
    © 2023 ACCURANT BIOTECH, INC.